 |
State-of-art centre located in NOIDA (India) equipped with the
latest instrumentation |
 |
 |
Dedicated groups focused on IR products (coated /uncoated
tablets,, bi-layered tablets, hard gelatin capsules, powder for oral
suspensions) and NDDS platforms (extended/delayed/sustained release,
Orally Disintegrating and Chewable tablets) |
 |
 |
Team of over 100 scientists |
 |
 |
Capable of developing 12 products per annum each for the US and
EU markets. Therapeutic categories in focus are CVS, CNS,
Anti-infective, Respiratory and Anti diabetics (currently focused on
oral solids) |
 |
 |
Developing formulations for the veterinary business. |
 |
 |
|
|